opensafely/ckd-coverage-ve
Parker, E
and Horne, E
(2022).
opensafely/ckd-coverage-ve.
[Dataset].
Github.
https://github.com/opensafely/ckd-coverage-ve
and Horne, E
(2022).
opensafely/ckd-coverage-ve.
[Dataset].
Github.
https://github.com/opensafely/ckd-coverage-ve
This is the code and configuration for OpenSAFELY. The study characterises factors associated with COVID-19 vaccine uptake among people with kidney disease in England.
Alternative Title
OpenSAFELY: COVID-19 vaccine coverage and effectiveness in kidney disease patients
Keywords
OpenSAFELY; COVID-19; Coronavirus; SARS-CoV-2; Vaccination| Item Type | Dataset |
|---|---|
| Resource Type |
Resource Type Resource Description Software R script |
| Capture method | Other |
| Date | 19 December 2022 |
| Language(s) of written materials | English |
| Creator(s) |
Parker, E and Horne, E
|
| LSHTM Faculty/Department | Faculty of Infectious and Tropical Diseases > Dept of Clinical Research |
| Participating Institutions | London School of Hygiene & Tropical Medicine, London, United Kingdom; University of Oxford, Oxford, Oxfordshire, United Kingdom; The Phoenix Partnership, Leeds, United Kingdom; The Francis Crick Institute, London, United Kingdom; University of Bristol, Bristol, United Kingdom; Kidney Care UK, Alton, United Kingdom; UK Renal Registry, Bristol, United Kingdom; NIHR Bristol Biomedical Research Centre, Bristol, United Kingdom; Health Data Research UK South-West, Bristol, United Kingdom; Imperial College London, London, United Kingdom; Imperial College Healthcare NHS Trust, London, United Kingdom; UK Renal Registry, Bristol, United Kingdom |
| Funders |
Project Funder Grant Number Funder URI UNSPECIFIED NIHR135559 http://dx.doi.org/10.13039/501100000272 UNSPECIFIED COV-LT2-0073 http://dx.doi.org/10.13039/501100000272 |
| Date Deposited | 17 Feb 2023 11:01 |
| Last Modified | 23 Feb 2026 16:39 |
| Publisher | Github |
Explore Further
- Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
- Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
No files available. Please consult associated links.
